circASCOR enhances platinum resistance  in ovarian cancer
We have employed a snRNA-seq to study circRNA ASCOR in ovarian cancer cisplatin resistance. Overall design: The expression level of circASCOR was detected by RT-qPCR, and samples were divided into high-expression and low-expression groups according to the expression level and analyzed using snRNA-seq.